SCHEMBL14099595

SCHEMBL14099595

CCNC(=O)C(CS)NC(C)=O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.64
MAPT P10636 1/20 0.64
THRB P10828 1/20 0.64
ALOX15 P16050 1/20 0.64
NFKB1 P19838 1/20 0.64
PTGS2 P35354 1/20 0.64
THPO P40225 1/20 0.64
RECQL P46063 1/20 0.64
BLM P54132 1/20 0.64
SMN1; SMN2 Q16637 1/20 0.64
ACE P12821 1/20 0.44
ALDH1A1 P00352 1/20 0.42
SIRT6 Q8N6T7 1/20 0.40
SIRT1 Q96EB6 1/20 0.40
CTSS P25774 1/20 0.37
CTSK P43235 1/20 0.37
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA3 P07451 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14611666 1.00 KDM4E (0.64) KDM4EMAPTTHRBALOX15NFKB1
SCHEMBL21153020 1.00 KDM4E (0.64) KDM4EMAPTTHRBALOX15NFKB1
SCHEMBL928644 0.86 KDM4E (0.61) KDM4EMAPTTHRBALOX15NFKB1
SCHEMBL4989506 0.86 ACE (0.46) KDM4EMAPTTHRBALOX15NFKB1
SCHEMBL12157363 0.85 KDM4E (0.55) KDM4EMAPTTHRBALOX15NFKB1
SCHEMBL4986815 0.84 ACE (0.44) KDM4EMAPTTHRBALOX15NFKB1
SCHEMBL14047526 0.83 SMN1; SMN2 (0.47) KDM4EMAPTTHRBALOX15NFKB1
SCHEMBL16438107 0.83 SMN1; SMN2 (0.47) KDM4EMAPTTHRBALOX15NFKB1
SCHEMBL931196 0.82 KDM4E (0.57) KDM4EMAPTTHRBALOX15NFKB1
SCHEMBL12157386 0.82 ACE (0.43) KDM4EMAPTTHRBALOX15NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230183746-A1 COMPOSITIONS FOR TRANSFER OF CARGO TO CELLS Sixfold Bioscience Ltd. (GB) 2023-06-15 US disclosed
US-20080160017-A1 Cross-Linked Antibodies UCB BIOPHARMA SPRL (BE) 2008-07-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080160017-A1 Cross-Linked Antibodies FCGR3B, CD47, FCGR2A KDM4E 2736/4885MAPT 2539/4885THRB 4178/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.